Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies

by University of Washington School of MedicineVaccine GPB510 is a tiny ball of protein studded with 60 copies of the SARS-CoV-2 Spike protein receptor-binding domain (red). Credit: Ian Haydon / U

Updated on: April 02,2024

Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies

by University of Washington School of MedicineVaccine GPB510 is a tiny ball of protein studded with 60 copies of the SARS-CoV-2 Spike protein receptor-binding domain (red). Credit: Ian Haydon / U

Updated on:April 02,2024

More mpox expected in Europe over the coming weeks, World Health Organization warns | BBC News

Updated on: August 19,2024

More mpox expected in Europe over the coming weeks, World Health Organization warns | BBC News

Updated on:August 19,2024

New study highlights COVID-19's adaptive strategy for infection

byUniversity of Minnesota Medical SchoolCryo-EM analyses of residue 417 in regulating the conformation of recombinant SARS-CoV-2 spike ectodomain. Prototypic SARS-CoV-2 spike ectodomains contain

Updated on: January 26,2024

New study highlights COVID-19's adaptive strategy for infection

byUniversity of Minnesota Medical SchoolCryo-EM analyses of residue 417 in regulating the conformation of recombinant SARS-CoV-2 spike ectodomain. Prototypic SARS-CoV-2 spike ectodomains contain

Updated on:January 26,2024

HIV antibody therapy is associated with enhanced immune responses in infected individuals

by University of Montreal Hospital Research CentreMicroscopic image of an HIV-infected T cell. Credit: NIAIDMost people living with HIV control the virus thanks to antiretroviral therapy (ART). Althou

Updated on: April 16,2024

HIV antibody therapy is associated with enhanced immune responses in infected individuals

by University of Montreal Hospital Research CentreMicroscopic image of an HIV-infected T cell. Credit: NIAIDMost people living with HIV control the virus thanks to antiretroviral therapy (ART). Althou

Updated on:April 16,2024

What causes the itch in mosquito bites? And why do some people get such a bad reaction?

by Cameron Webb,The ConversationCredit: Arthur Poulin/UnsplashAre you one of these people who loathes spending time outdoors at dusk as the weather warms and mosquitoes start biting?Female mosqu

Updated on: December 05,2024

What causes the itch in mosquito bites? And why do some people get such a bad reaction?

by Cameron Webb,The ConversationCredit: Arthur Poulin/UnsplashAre you one of these people who loathes spending time outdoors at dusk as the weather warms and mosquitoes start biting?Female mosqu

Updated on:December 05,2024

Learning from COVID-19: Why We Cannot Afford Collective Amnesia

Now, more than half a decade later, many people are eager to move on and forget the disruptions caused by lockdowns, social distancing, and relentless health protocols.

Updated on: January 22,2025

Learning from COVID-19: Why We Cannot Afford Collective Amnesia

Now, more than half a decade later, many people are eager to move on and forget the disruptions caused by lockdowns, social distancing, and relentless health protocols.

Updated on:January 22,2025

Study identifies increase in antibiotic-resistant typhoid

by University of LiverpoolCiprofloxacin-sensitive, DCS, or ciprofloxacin-resistant phenotypes among S Typhi isolated from Queen Elizabeth Central Hospital, by month. Ciprofloxacin susceptibility

Updated on: June 04,2024

Study identifies increase in antibiotic-resistant typhoid

by University of LiverpoolCiprofloxacin-sensitive, DCS, or ciprofloxacin-resistant phenotypes among S Typhi isolated from Queen Elizabeth Central Hospital, by month. Ciprofloxacin susceptibility

Updated on:June 04,2024

Investigators explore what factors increase susceptibility to COVID-19

by Cedars-Sinai Medical CenterHeritability and shared environment estimates over time for SARS-CoV-2 susceptibility. a) Cumulative heritability and shared environment estimates with 95% CI. Cente

Updated on: June 14,2024

Investigators explore what factors increase susceptibility to COVID-19

by Cedars-Sinai Medical CenterHeritability and shared environment estimates over time for SARS-CoV-2 susceptibility. a) Cumulative heritability and shared environment estimates with 95% CI. Cente

Updated on:June 14,2024

Researchers identify way to block alphavirus infection

by Washington University in St. LouisCredit:Cell(2023). DOI: 10.1016/j.cell.2023.09.007Researchers at Washington University School of Medicine in St. Louis have found an innovative wa

Updated on: June 01,2024

Researchers identify way to block alphavirus infection

by Washington University in St. LouisCredit:Cell(2023). DOI: 10.1016/j.cell.2023.09.007Researchers at Washington University School of Medicine in St. Louis have found an innovative wa

Updated on:June 01,2024

Stem cell study shows how gene activity modulates the amount of immune cell production in mice

byKeck School of Medicine of USCCredit: CC0 Public DomainAs people age or become ill, their immune systems can become exhausted and less capable of fighting off viruses such as the flu or COVID-

Updated on: April 22,2024

Stem cell study shows how gene activity modulates the amount of immune cell production in mice

byKeck School of Medicine of USCCredit: CC0 Public DomainAs people age or become ill, their immune systems can become exhausted and less capable of fighting off viruses such as the flu or COVID-

Updated on:April 22,2024

Pathogens use force to breach immune defenses, study finds

by Kevin Fryling,Indiana UniversityCredit: Pixabay/CC0 Public DomainSimilar to a burglar breaking a window to get into a house, Indiana University researchers have discovered a previously unknow

Updated on: January 26,2024

Pathogens use force to breach immune defenses, study finds

by Kevin Fryling,Indiana UniversityCredit: Pixabay/CC0 Public DomainSimilar to a burglar breaking a window to get into a house, Indiana University researchers have discovered a previously unknow

Updated on:January 26,2024

A vaccine against chronic inflammatory diseases

by Institut National de la Sante et de la Recherche MedicaleCredit: CC0 Public DomainIn animals, a vaccine modifying the composition and function of the gut microbiota provides protection against

Updated on: April 01,2024

A vaccine against chronic inflammatory diseases

by Institut National de la Sante et de la Recherche MedicaleCredit: CC0 Public DomainIn animals, a vaccine modifying the composition and function of the gut microbiota provides protection against

Updated on:April 01,2024